The FTC’s five Commissioners issue statements on a range of important topics to engage with the public and express the views of the Commission as well as their own individual views.
Displaying 761 - 780 of 1010
Statement of Commissioner Rosch, Concurring in Part and Dissenting in Part - In the Matter of McWane, Inc., a corporation, and Star Pipe Products, Ltd
Date
By
J. Thomas Rosch, Former Commissioner
Matter Number
101 0080b
Docket Number
9351
Dissenting Statement of Commissioner Ramirez, In the Matter of North Carolina Board of Dental Examiners, The
Date
By
Edith Ramirez, Former Chairwoman
Matter Number
081 0137
Docket Number
9343
Statement of Commissioner Rosch, Concurring In Part and Dissenting In Part - In the Matter of McWane, Inc and Star Pipe Products, Ltd, and In the Matter of Sigma Corporation
Date
By
J. Thomas Rosch, Former Commissioner
Matter Number
101 0080b
Docket Number
9351
Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs
Date
By
Mary K. Engle, Associate Director
Statement of Commissioners Leibowitz, Kovacic, and Ramirez, In the Matter of Laboratory Corporation of America and Laboratory Corporation of America Holdings
Date
By
Matter Number
101 0152
Docket Number
9345
Concurring Statement of Commissioner Brill, In the Matter of Laboratory Corporation of America and Laboratory Corporation of America Holdings
Date
By
Julie Brill, Former Commissioner
Matter Number
101 0152
Docket Number
9345
Preliminary FTC Staff Privacy Report
Date
By
Jon Leibowitz, Former Chairman
File
Preliminary FTC Staff Privacy Report
(15.19 KB)
Statement of the Commission, In the Matter of Laboratory Corporation of America and Laboratory Corporation of America Holdings
Date
Matter Number
101 0152
Docket Number
9345
Dissenting Statement of Commissioner Rosch, In the Matter of Laboratory Corporation of America and Laboratory Corporation of America Holdings
Date
By
J. Thomas Rosch, Former Commissioner
Matter Number
101 0152
Docket Number
9345
Displaying 761 - 780 of 1010